Dacarbazine : Déticène® = Dacarbazine : Deticene®QUEREUX, G; BROCARD, A; DRENO, B et al.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 1001-1003, issn 0151-9638, 3 p.Article

Biological reactive intermediates that mediate dacarbazine cytotoxicityPOURAHMAD, Jalal; AMIRMOSTOFIAN, Marzieh; KOBARFARD, Farzad et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 89-96, issn 0344-5704, 8 p.Article

Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosisSANADA, Masayuki; HIDAKA, Masumi; TAKAGI, Yasumitsu et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 12, pp 2657-2663, issn 0143-3334, 7 p.Article

Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivoLEV, Dina Chelouche; ONN, Amir; MELINKOVA, Vladislava O et al.Journal of clinical oncology. 2004, Vol 22, Num 11, pp 2092-2100, issn 0732-183X, 9 p.Article

Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimensCHIARION-SILENI, V; GUIDA, M; RIDOLFI, L et al.British journal of cancer. 2011, Vol 104, Num 12, pp 1816-1821, issn 0007-0920, 6 p.Article

Anti-Melanoma Activity of the 9.2.27PE Immunotoxin in Dacarbazine Resistant CellsRISBERG, Karianne; FODSTAD, Øystein; ANDERSSON, Yvonne et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 3, pp 272-278, issn 1524-9557, 7 p.Article

Efficacité spectaculaire d' une chimiothérapie par 5-fluoro-uracile et dacarbazine chez un malade atteint de glucagonome métastatique avec insuffisance cardiaque = Dramatic efficacy of chemotherapy with 5-fluoro-uracile and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiencyDE MESTIER, L; HAMMEL, P; HENTIC, O et al.Gastroentérologie clinique et biologique. 2010, Vol 34, Num 1, pp 106-110, issn 0399-8320, 5 p.Article

Liver Metastases from Uveal Melanoma: Clinical Experience of Hepatic Arterial Infusion of Cisplatin, Vinblastine and DacarbazineMELICHAR, Bohuslav; VOBORIL, Zbynek; LOJIK, Miroslav et al.Hepato-gastroenterology. 2009, Vol 56, Num 93, pp 1157-1162, issn 0172-6390, 6 p.Article

Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma : A Report From the 11715 Study GroupMCDERMOTT, David F; SOSMAN, Jeffrey A; FRENETTE, Gary et al.Journal of clinical oncology. 2008, Vol 26, Num 13, pp 2178-2185, issn 0732-183X, 8 p.Article

Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology GroupTERHEYDEN, P; KORTÜM, A. K; BECKER, J. C et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 7, pp 437-444, issn 0171-5216, 8 p.Article

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma : The oblimersen melanoma study groupBEDIKIAN, Agop Y; MILLWARD, Michael; KIRKWOOD, John M et al.Journal of clinical oncology. 2006, Vol 24, Num 29, pp 4738-4745, issn 0732-183X, 8 p.Article

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma : a randomized phase III trial of the DC study group of the DeCOGSCHADENDORF, D; UGUREL, S; ZIMPFER-RECHNER, C et al.Annals of oncology. 2006, Vol 17, Num 4, pp 563-570, issn 0923-7534, 8 p.Article

Long-term events in adult patients with clinical stage IA-IIA nonbulky hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin,vinblastine, and dacarbazine and adjuvant radiotherapy : A single-institution 15-year follow-upBRUSAMOLINO, Ercole; BAIO, Ambrogia; ORLANDI, Ester et al.Clinical cancer research. 2006, Vol 12, Num 21, pp 6487-6493, issn 1078-0432, 7 p.Article

Enhancement of biomolecular recognition of DTIC based on functional monodisperse polystyrene spheresRENYUN ZHANG; HAIHUA CHEN; CHUNHUI WU et al.Macromolecular rapid communications. 2005, Vol 26, Num 18, pp 1469-1472, issn 1022-1336, 4 p.Article

Artesunate in the treatment of metastatic uveal melanoma : first experiencesBERGER, Thomas G; DIECKMANN, Detlef; EFFERTH, Thomas et al.Oncology reports. 2005, Vol 14, Num 6, pp 1599-1603, issn 1021-335X, 5 p.Article

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastasesBERNSEN, M. R; HAKANSSON, L; GUSTAFSSON, B et al.British journal of cancer. 2003, Vol 88, Num 3, pp 424-431, issn 0007-0920, 8 p.Article

Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945FOULADI, Maryam; HUNT, Daniel L; FINLAY, Jonathan L et al.Cancer. 2003, Vol 98, Num 6, pp 1243-1252, issn 0008-543X, 10 p.Article

Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)ATZPODIEN, J; NEUBER, K; PAUL, E et al.British journal of cancer. 2002, Vol 86, Num 2, pp 179-184, issn 0007-0920Article

Immunohistochemical analysis of DNA mismatch repair protein and O⁶-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapySHUHUA MA; EGYHAZI, Suzanne; RINGBORG, Ulrik et al.Oncology reports. 2002, Vol 9, Num 5, pp 1015-1019, issn 1021-335XArticle

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomasMERIC, Funda; HESS, Kenneth R; BURGESS, Michael A et al.Cancer. 2002, Vol 95, Num 5, pp 1120-1126, issn 0008-543XArticle

High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanomaO'DAY, Steven J; BOASBERG, Peter D; KRISTEDJA, Tim S et al.Cancer. 2001, Vol 92, Num 3, pp 609-619, issn 0008-543XConference Paper

Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease : A prospective, multi-institutional AIDS Clinical Trials Group Study (ACTG 149)LEVINE, Alexandra M; PING LI; CHEUNG, Tony et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 24, Num 5, pp 444-450, issn 1525-4135Article

Risk-adapted therapy for clinical Stage I-II Hodgkin's disease : 7-year results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk diseaseMACKENZIE, R. G; FRANSSEN, E; WONG, R et al.Clinical oncology (Springer. Print). 2000, Vol 12, Num 5, pp 278-288, issn 0936-6555Conference Paper

Combination of chemotherapy with interleukin-2 and interferon alfa for the treatment of metastatic melanomaRICHARDS, J. M; GALE, D; MEHTA, N et al.Journal of clinical oncology. 1999, Vol 17, Num 2, pp 651-657, issn 0732-183XArticle

Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracilICLI, F; ARICAN, A; CAY, F et al.Oncology. 1999, Vol 56, Num 4, pp 297-300, issn 0030-2414Article